A new recombinant factor VIII: from genetics to clinical use

A new recombinant factor VIII: from genetics to clinical use

Christoph Kannicht,1 Guido Kohla,1 Maya Tiemeyer,2 Olaf Walter,3 Helena Sandberg4 1Octapharma Biopharmaceuticals GmbH, Molecular Biochemistry, Berlin, Germany; 2Octapharma Biopharmaceuticals GmbH, Heidelberg, Germany; 3Octapharma AG, Lachen, Switzerland; 4CoaBio AB, Bromma, SwedenThe December 2014...

Full description

Bibliographic Details
Main Authors: Kannicht C, Kohla G, Tiemeyer M, Walter O, Sandberg H
Format: Article
Language:English
Published: Dove Medical Press 2015-07-01
Series:Drug Design, Development and Therapy
Online Access:http://www.dovepress.com/letter-a-new-recombinant-factor-viii-from-genetics-tonbspclini-peer-reviewed-article-DDDT

Internet

http://www.dovepress.com/letter-a-new-recombinant-factor-viii-from-genetics-tonbspclini-peer-reviewed-article-DDDT

Similar Items